# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4420560 | F | Cytotoxicity against human NCI-H1703 cells assessed as cell viability at 1 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 68 | cell-based format | Patent Bioactivity Data | ||
2. | ALA4420561 | F | Cytotoxicity against human NCI-H1703 cells assessed as cell viability at 10 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 61 | cell-based format | Patent Bioactivity Data | ||
3. | ALA4420563 | F | Cytotoxicity against human NCI-H226 cells assessed as cell viability at 1 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 68 | cell-based format | Patent Bioactivity Data | ||
4. | ALA4420564 | F | Cytotoxicity against human NCI-H226 cells assessed as cell viability at 10 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 61 | cell-based format | Patent Bioactivity Data | ||
5. | ALA4420565 | F | Cytotoxicity against human A549 cells assessed as cell viability at 1 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 60 | cell-based format | Patent Bioactivity Data | ||
6. | ALA4420566 | F | Cytotoxicity against human A549 cells assessed as cell viability at 10 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 53 | cell-based format | Patent Bioactivity Data | ||
7. | ALA4420567 | F | Cytotoxicity against human NCI-H358 cells assessed as cell viability at 1 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 64 | cell-based format | Patent Bioactivity Data | ||
8. | ALA4420568 | F | Cytotoxicity against human NCI-H358 cells assessed as cell viability at 10 uM incubated for 48 hrs by MTT assay relative to control | Homo sapiens | 57 | cell-based format | Patent Bioactivity Data | ||
9. | ALA4420575 | B | Inhibition of His-tagged recombinant human SET1 protein (1 to 290 amino acids) expressed in Escherichia coli interaction with N-terminal GST-tagged recombinant human PP2A-C (1 to 309 amino acids) assessed as minimal concentration causing disruption of SET-PP2Ac binding by SPR assay | Homo sapiens | 19 | assay format | Patent Bioactivity Data | ||
10. | ALA4420576 | B | Activation of PP2A in human HA22T cells assessed as minimal concentration causing increase in protein phosphatase activity incubated for 24 hrs using phosphopeptide substrate incubated for 10 mins by malachite green-phosphate complex assay | Homo sapiens | 20 | cell-based format | Patent Bioactivity Data | ||
11. | ALA4420577 | B | Activation of PP2A in human PLC5 cells assessed as minimal concentration causing increase in protein phosphatase activity incubated for 24 hrs using phosphopeptide substrate incubated for 10 mins by malachite green-phosphate complex assay | Homo sapiens | 20 | cell-based format | Patent Bioactivity Data | ||
12. | ALA4420578 | B | Activation of PP2A in human Hep3B cells assessed as minimal concentration causing increase in protein phosphatase activity incubated for 24 hrs using phosphopeptide substrate incubated for 10 mins by malachite green-phosphate complex assay | Homo sapiens | 20 | cell-based format | Patent Bioactivity Data | ||
13. | ALA4420579 | B | Activation of PP2A in human SKHEP1 cells assessed as minimal concentration causing increase in protein phosphatase activity incubated for 24 hrs using phosphopeptide substrate incubated for 10 mins by malachite green-phosphate complex assay | Homo sapiens | 20 | cell-based format | Patent Bioactivity Data |